Identification of sequences required for inhibition of oncogene-mediated transformation by pp32

J R Brody1, S S Kadkol, M A Mahmoud

  • 1Division of Molecular Pathology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Insights

The pp32 tumor suppressor protein inhibits cancer growth. Specific amino acids 150-174 are crucial for this tumor-suppressive function, distinguishing it from related oncogenic proteins.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Prostate cancer progression involves altered expression of the pp32 gene family.
  • The pp32 family contains tumor-suppressive (pp32) and pro-oncogenic (pp32r1, pp32r2) members.
  • Despite high protein sequence identity, pp32 family members exhibit opposing functions.

Purpose of the Study:

  • To identify the specific region of pp32 responsible for its tumor-suppressive activity.
  • To understand how sequence variations in pp32 family members contribute to oncogenic potential.

Main Methods:

  • Deletion and truncation analysis of the pp32 protein.
  • In vitro transformation assays using rat embryo fibroblasts.
  • Sequence comparison between pp32, pp32r1, and pp32r2.

Main Results:

  • A region spanning amino acids 150-174 of pp32 was identified as essential for inhibiting RAS and MYC-induced transformation.
  • Sequence divergence within this region between pp32 and its oncogenic relatives (pp32r1, pp32r2) was observed.
  • pp32r2 showed truncation after amino acid 131, differing in this critical region.

Conclusions:

  • The tumor-suppressive function of pp32 is localized to amino acids 150-174.
  • This minimal functional region is key to understanding the opposing roles of pp32 family members in cancer.
  • Findings provide a basis for further research into pp32-mediated pathways in cancer.